share_log

BioCryst Pharmaceuticals | 8-K: BioCryst Reports Second Quarter 2023 Financial Results and Provides Business Update

SEC announcement ·  Aug 3, 2023 07:04
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more